List of Excipients in Branded Drug SODIUM ACETATE

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Hospira Inc	SODIUM ACETATE	sodium acetate	0409-3299	ACETIC ACID
Hospira Inc	SODIUM ACETATE	sodium acetate	0409-3299	WATER
Hospira Inc	SODIUM ACETATE	sodium acetate	0409-7299	ACETIC ACID
Hospira Inc	SODIUM ACETATE	sodium acetate	0409-7299	WATER

Generic Drugs Containing SODIUM ACETATE

Company	Ingredient	NDC	Excipient
Hikma Pharmaceuticals USA Inc	sodium acetate	0641-6261	ACETIC ACID
Hikma Pharmaceuticals USA Inc	sodium acetate	0641-6261	WATER
Hikma Pharmaceuticals USA Inc	sodium acetate	0641-6262	ACETIC ACID
Hikma Pharmaceuticals USA Inc	sodium acetate	0641-6262	WATER
Fresenius Kabi USA LLC	sodium acetate	63323-032	ACETIC ACID
Fresenius Kabi USA LLC	sodium acetate	63323-032	WATER

What are the Most Frequently-Used Excipients in SODIUM ACETATE?

# Of NDCs	Excipient
8	ACETIC ACID
8	WATER

Excipient Strategy and Commercial Opportunities for Sodium Acetate in Pharmaceuticals

Last updated: February 28, 2026

What is the Role of Sodium Acetate as an Excipient?

Sodium acetate is used primarily as a buffering agent and pH regulator in pharmaceutical formulations. It stabilizes pH levels in solutions, which is critical for maintaining drug stability and bioavailability. It also serves as an electrolyte source in infusion fluids and as a buffering agent in topical and injectable formulations.

How Does Sodium Acetate Contribute to Drug Stability and Manufacturing?

Sodium acetate’s buffering capacity ensures the maintenance of optimal pH during drug storage and administration, preventing degradation. Its water-soluble nature simplifies formulation processes and enhances compatibility with various active pharmaceutical ingredients (APIs). It is also cost-effective, non-toxic, and readily available, supporting large-scale manufacturing.

Feature	Description
pH range	Typically buffers pH 4.0 to 5.5
Solubility	Highly soluble in water
Toxicity	Considered non-toxic, safe for injection
Cost	Low-cost, widely available

What Are the Commercial Opportunities Driven by Regulatory and Market Trends?

• Expanded Use in Biopharmaceuticals: As biologics and biosimilars grow, formulations require precise pH control. Sodium acetate provides a stable, safe buffering solution compliant with regulatory standards.

• Injectable and IV Fluid Growth: Sodium acetate is a key component in intravenous fluids, especially in electrolyte replenishment solutions. The global IV fluid market is projected to reach USD 22 billion by 2026 [1], providing a sizable opportunity for suppliers.

• Sterile and Pre-filled Formulation Markets: The demand for sterile buffer solutions and pre-filled syringes enhances the market for pharmaceutical-grade sodium acetate, which must meet stringent regulatory standards (USP, EP, JP).

• Cost-Effective Formulation Enhancer: As pharmaceutical companies seek to reduce production costs, sodium acetate’s low price increases its attractiveness as a buffering agent in large-scale drug manufacturing.

What Regulatory Considerations Affect Sodium Acetate as an Excipient?

Chemical grade standards such as USP, EP, and JP certify pharmaceutical-grade sodium acetate. Regulatory agencies review excipients for purity, stability, and safety. Markets with strict regulations (U.S., EU, Japan) require comprehensive documentation, including stability data and manufacturing controls.

How Does the Competitive Landscape Shape the Supply and Innovation Opportunities?

Major suppliers of pharmaceutical-grade sodium acetate include:

• FMC Corporation
• Jiangsu Shuangyang Chemical
• Sigma-Aldrich (Merck)

The market remains competitive with low entry barriers due to the commodity nature of the excipient. Innovation focuses on:

• Developing stabilized, high-purity formulations
• Producing sterile, lyophilized, or pre-filled versions optimized for specific delivery routes
• Enhancing supply chain resilience to meet rising demand

What Are the Key Challenges and Risks?

• Regulatory Compliance: Ensuring ongoing adherence to evolving standards.
• Supply Chain Disruptions: Raw material availability and geopolitical factors may impact sourcing.
• Market Saturation: Limited differentiation among raw material suppliers requires focus on cost competitiveness and quality assurance.

What Future Trends Could Impact Sodium Acetate’s Excipient Role?

• Growth in Personalized Medicine: Custom formulations may require modified buffering solutions, opening niche markets.
• Biopharmaceutical Innovations: Advanced delivery systems might demand specialized excipients with improved stability profiles, potentially leading to new formulations replacing or supplementing sodium acetate.
• Sustainability and Green Chemistry: Eco-friendly manufacturing processes could become a market differentiator.

Key Takeaways

• Sodium acetate is a cost-effective, safety-validated buffering agent integral to pharmaceutical formulations.
• The expanding IV fluid and biologic markets drive sustained demand.
• Regulatory standards ensure quality but require ongoing compliance.
• Competitive supply has room for innovation in sterile, stable formulations.
• Supply chain resilience and regulatory adherence pose ongoing challenges.

FAQs

1. Can sodium acetate be used in both oral and injectable formulations?
Yes. Its biological safety profile allows use in oral solutions and injectable formulations, including IV fluids.

2. What are the main regulatory standards affecting the pharmaceutical-grade sodium acetate?
USP, EP, and JP standards govern purity, stability, and manufacturing practices.

3. Is there room for innovation in sodium acetate-based excipients?
Yes. Development of sterile, pre-filled, or stabilized formulations presents opportunities.

4. How significant is the market for intravenous solutions containing sodium acetate?
The global IV fluid market, valued at USD 15 billion in 2020, offers considerable opportunities, especially for electrolyte-replenishing solutions.

5. What are primary competitors in sodium acetate supply?
Major suppliers include FMC Corporation, Jiangsu Shuangyang Chemical, and Sigma-Aldrich. Market entry is accessible due to low commodity costs, but differentiation depends on quality and product specifications.

References

1. Grand View Research. (2022). Intravenous (IV) Fluid Market Size, Share & Trends Analysis Report.